EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy of Gonadotropin Therapy to Induce Spermatogenesis and Fertility in Men with Pathologic Gonadotropin Deficiency

Joshua V Gialouris iD, Ann J Conway, Amanda Idan, Sasha Savkovic iD, Raquel Hermosilla, Christopher A Muir iD, Feyrous Bacha, Ting Zhang, Wanxin Hou, Veena Jayadev iD, David J Handelsman iD

The Journal of Clinical Endocrinology & Metabolism · 22.04.2026 · 111 (5) · 1450-1458

DOI: 10.1210/clinem/dgaf588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 30.10.2025. Verfasst von Joshua V Gialouris und 10 weiteren Autor:innen. Beteiligte Einrichtung: ANZAC Research Institute, University of Sydney, Sydney, NSW 2138, Australia. Hauptthemen laut MEDLINE: Spermatogenesis, Infertility, Male, Chorionic Gonadotropin, Fertility. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Gonadotropin treatment to induce spermatogenesis for gonadotropin-deficient men is the only medically treatable cause of male infertility. However, time-dependent analyses of fertility outcomes in large cohorts are lacking. We evaluated the time to, and determinants of, fertility outcomes in men with pathologic gonadotropin-deficiency undergoing gonadotropin treatment.

Methods

Consecutive infertile men (n = 99) with congenital or acquired pathologic gonadotropin deficiency were treated with urinary or recombinant human chorionic gonadotropin and FSH according to a standardized protocol between 1983 and 2024. Kaplan-Meier and multivariate Cox regression analyses examined time to prespecified sperm density thresholds and pregnancy.

Results

Men aged 35 ± 1 years with female partners 30 ± 1 years underwent 160 treatment cycles. The proportion (%) and median time (months) to achieve sperm thresholds of >0, >2, >5, >10, and >20 million (M) sperm/mL was 78% (5 months), 56% (12 months), 49% (14 months), 37% (21 months), and 24% (not determined), respectively. The major determinant of successful pregnancy was the presence of adverse fertility factors in the female partner (hazard ratio 0.20, 95% confidence interval 0.10-0.40; P < .001), with time to pregnancy also significantly increased by the presence of adverse female factors (15 vs 43 months; P < .0001). The median sperm concentration associated with partner pregnancy was 2.8 (0.2, 52.6) M/mL without and 35.4 (15.1, 52.6) M/mL with adverse female factors.

Conclusion

Most men with pathologic gonadotropin deficiency treated with hCG/FSH achieve sperm output and fertility within a year, with the greatest impact on fertility outcomes being detrimental female fertility factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpermatogenesisInfertility, MaleChorionic GonadotropinFertilityFollicle Stimulating HormoneGonadotropinsHumansMaleAdultFemalePregnancyTreatment OutcomeRetrospective StudiesPregnancy Rate

Stichwörter der Autor:innen

fertilitygonadotropin deficientgonadotropin treatmenthypogonadotropic hypogonadismmensperm production

Substanzen

Chorionic GonadotropinFollicle Stimulating HormoneGonadotropins

Autor:innen und Institutionen

  • ANZAC Research Institute, University of Sydney, Sydney, NSW 2138, Australia.
  • Andrology, Concord Hospital, Sydney, NSW 2139, Australia.

ORCID-Profile: Joshua V Gialouris, Sasha Savkovic, Christopher A Muir, Veena Jayadev, David J Handelsman

Zitieren

APA

Gialouris, J. V., Conway, A. J., Idan, A., Savkovic, S., Hermosilla, R., Muir, C. A., Bacha, F., Zhang, T., Hou, W., Jayadev, V., & Handelsman, D. J. (2026). Efficacy of Gonadotropin Therapy to Induce Spermatogenesis and Fertility in Men with Pathologic Gonadotropin Deficiency. The Journal of Clinical Endocrinology & Metabolism, 111(5), 1450-1458. https://doi.org/10.1210/clinem/dgaf588

Vancouver

Gialouris JV, Conway AJ, Idan A, Savkovic S, Hermosilla R, Muir CA, et al. Efficacy of Gonadotropin Therapy to Induce Spermatogenesis and Fertility in Men with Pathologic Gonadotropin Deficiency. The Journal of Clinical Endocrinology & Metabolism. 2026;111(5):1450-1458. doi:10.1210/clinem/dgaf588

BibTeX
@article{Gialouris2026,
  author = {Gialouris, Joshua V and Conway, Ann J and Idan, Amanda and Savkovic, Sasha and Hermosilla, Raquel and Muir, Christopher A and Bacha, Feyrous and Zhang, Ting and Hou, Wanxin and Jayadev, Veena and Handelsman, David J},
  title = {Efficacy of Gonadotropin Therapy to Induce Spermatogenesis and Fertility in Men with Pathologic Gonadotropin Deficiency},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {5},
  pages = {1450--1458},
  doi = {10.1210/clinem/dgaf588}
}
Kostenlos starten →